In silico screening of ginsenoside Rh1 with PPARγ and in vitro analysis on 3T3-L1 cell line

Molecular Simulation

Volumn 41, Issue 15, 2015, Pages 1219-1226

  Siraj, Fayeza M ^a   Natarajan, Sathishkumar ^a   Kim, Yeon Ju ^a   Chun Yang, Deok ^a  

^a Kyung Hee University   (South Korea)

Author keywords

3T3 L1 adipocyte; computational screening; ginsenoside Rh1; obesity; PPARg

Indexed keywords

BINDING ENERGY; CELL CULTURE; HYDROGEN BONDS; MAMMALS; MOLECULAR DYNAMICS; NUTRITION; PROTEINS; TRANSCRIPTION;

3T3-L1 ADIPOCYTE; GENE EXPRESSION LEVELS; GINSENOSIDE RH1; HYDROGEN BOND INTERACTION; OBESITY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PHARMACOKINETIC PROPERTIES; PPARG;

DIAGNOSIS;

EID: 84938420180     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927022.2014.970188     Document Type: Article

References (43)

1. Jou PC, Ho BY, Hsu YW, Pan TM. The effect of Monascus secondary polyketide metabolites, monascin and ankaflavin, on adipogenesis and lipolysis activity in 3T3-L1. J Agric Food Chem. 2010; 22: 12703-12709.
2. Tang QQ, Jiang MS, Lane MD. Repressive effect of Sp1 on the C/EBPalpha gene promoter: role in adipocyte differentiation. Mol Cell Biol. 1999; 19: 4855-4865.
3. Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab. 2001; 280: E827-E847.
4. Jeon T, Hwang SG, Hirai S, Matsui T, Yano H, Kawada T, Lim BO, Park DK. Red yeast rice extracts suppress adipogenesis by down-regulating adipogenic transcription factors and gene expression in 3T3-L1 cells. Life Sci. 2004; 12: 3195-3203.
5. Wilson TM, Wahli W. Peroxisome proliferator-activated receptor agonists. Curr Opin Chem Biol. 1997; 1: 235-241.
6. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994; 79: 1147-1156.
7. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994; 8: 1224-1234.
8. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011; 28: 722-734.
9. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998; 78: 783-809.
10. Abdollah M, Afshar IB. A review on obesity and weight loss measures. Middle East Pharm. 2003; 11: 6-10.
11. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999; 58: 1685-1693.
12. Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009; 7: 293-302.
13. Young JL, Young RJ, Won CL, Sang MJ, Songho C, Siyoul J, Seung L. A ginsenoside Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol. 2003; 84: 463-468.
14. Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses anti allergic and anti inflammatory activites. Int Arch Allergy Immunol. 2004; 133: 113-120.
15. Ma DL, Chana DSH, Leung CH. Molecular docking for virtual screening of natural product databases. Chem Sci. 2011; 2: 1656-1665.
16. Sohn YS, Lee Y, Park C, Hwang S, Kim S, Baek A, Son M, Suh JK, Kim HH, Lee KW. Pharmacophore identification for peroxisome proliferator-activated receptor gamma agonists. Bull Korean Chem Soc. 2011; 32: 201-207.
17. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H. The protein data bank. Nucleic Acids Res. 2000; 28: 235-242.
18. Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit. 1996; 9: 1-5.
19. Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997; 267: 727-748.
20. Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol. 1996; 261: 470-489.
21. Morris GM, Goodsell DS, Halliday RS. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. 1998; 19: 1639-1662.
22. Park H, Lee J, Lee S. Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Proteins: Struct Funct Bioinform. 2006; 65: 549-554.
23. Bursulaya BD, Totrov M, Abagyan R, Brooks CL. Comparative study of several algorithms for flexible ligand docking. J Comput Aided Mol Des. 2003; 17: 755-763.
24. Sathishkumar N, Sathiyamoorthy S, Ramya M, Yang DU, Lee HN, Yang DC. Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng. J Enzyme Inhib Med Chem. 2012; 27: 685-692.
25. Spoel DVD, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26: 1701-1718.
26. Christen M, Hunenberger PH, Bakowies D, Baron R, Burgi R, Geerke DP, Heinz TN, Kastenholz MA, Krautler V, Oostenbrink C, Peter C, Trzesniak D, van Gunsteren WF. The GROMOS software for biomolecular simulation: GROMOS05. J Comput Chem. 2005; 26: 1719-1751.
27. Ljungh A, Moran AP, Wadström T. Interactions of bacterial adhesins with extracellular matrix and plasma proteins: pathogenic implications and therapeutic possibilities FEMS. Med Microbiol. 1996; 16: 117-126.
28. Schuttelkopf AW, van Aalten DMF. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004; 60: 1355-1363.
29. Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997; 18: 1463-1472.
30. Karpagam V, Sathishkumar N, Sathiyamoorthy S, Periannan R, Samuel S, Kim YJ, Yang DC. Identification of BACE1 inhibitors from Panax ginseng saponins-an Insilco approach. Comput Biol Med. 2013; 43: 1037-1044.
31. Sathishkumar N, Karpagam V, Sathiyamoorthy S, Min JW, Kim YJ, Yang DC. Computer-aided identification of EGFR tyrosine kinase inhibitors using ginsenosides from Panax ginseng. Comput Biol Med. 2013; 43: 786-797.
32. Lagunin A, Stepanchikova A, Filimonov D, Poroikov V. PASS: prediction of activity spectra for biological active substances. Bioinform Appl Notes. 2000; 16: 747-748.
33. Lagunin A, Filimonov D, Poroikov V. Multi-targeted natural products evaluation based on biological activity prediction with PASS. Curr Pharm Des. 2010; 16: 1703-1717.
34. Fayeza MS, Natarajan S, Yeon JK, Deok CY. Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte differentiation in the 3T3-L1 cell line. J Enzyme Inhib Med Chem. 2014. doi:10.3109/14756366.2013.871006.
35. Yushma BA, Therese R, Michael RJ, Christos K, Jon S, Robert GC, Joseph MS, William DOH, Jonathan RH, Rolf KB, Andrew DM. Synthesis of novel PPAR /γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program PROTOBUILD. Org Biomol Chem. 2011; 9: 1169-1188.
36. Bruning JB, Chalmers MJ, Prasad S, Busby SA, Kamenecka TM, He Y, Nettles KW, Griffin PR. Partial agonists activate PPARg using a helix 12 independent mechanism. Structure. 2007; 15: 1258-1271.
37. Mohan CG, Gandhi T, Garg D, Shinde R. Computer-assisted methods in chemical toxicity pre diction. Mini Rev Med Chem. 2007; 7: 499-507.
38. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology. 2000; 141: 3388-3396.
39. Kovsan J, Ben RR, Souza SC, Greenberg AS, Rudich A. Regulation of adipocyte lipolysis by degradation of the Perilipin protein. J Biol Chem. 2007; 282: 21704-21711.
40. Blanchette MEJ, Dwyer NK, Barber LT, Coxey RA, Takeda T, Rondinone CM, Theodorakis JL, Greenberg AS, Londost C. Perilipin is located on the surface layer of intracellular lipid droplets in adipocytes. J Lipid Res. 1995; 36: 1211-1226.
41. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 2000; 16: 145-171.
42. Wan G, Kyung AK, Dong HK. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol Pharm Bull. 2013; 36: 102-107.
43. Fayeza MS, Yeon JK, Natarajan S, Seok KJ, Dong UY, Deok CY.,. Ginseng and obesity: observations from assorted perspectives. Food Sci Biotechnol. 2014; 23: 1007-1016.